Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-05

Clinical Trial Update: Botensilimab and Balstilimab Optimization in Colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update on optimizing the combination of Botensilimab and Balstilimab in colorectal cancer. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Balstilimab (balstilimab)
  • Botensilimab (botensilimab)

Snippet

Sponsor: Nicholas DeVito, MD | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING